Surgalign Holdings Inc (SRGA) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket
 


Surgalign Holdings Inc   (NASDAQ: SRGA)


Surgalign Holdings Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Surgalign Holdings Inc's ROI in the first quarter of 2023?
Surgalign Holdings Inc recorded a cumulative net loss of $-50 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -103.73%.

Within the Healthcare sector 738 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 4279 to 4661.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM -31.09 % -30.95 % -36.51 % -32.39 % 16.48 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 48 49 53 45 49
Return On Investment (TTM) -103.73 % -111.41 % -230.45 % -192.03 % -157.62 %
SRGA's Overall Ranking # 4661 # 4279 # 0 # 0 # 0
Seq. Investment Change TTM -0.7 % 9.92 % -15.08 % -25.66 % -0.49 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -50 -55 -103 -101 -111




Return On Investment SRGA's Ranking
Within: No.
Industry # 173
Sector # 739
Overall # 4661

Return On Investment Statistics
High Average Low
33.52 %
-56.59 %
-150.78 %
(Dec 31 2018)   (Sep 30 2020)







Financial Statements
Surgalign Holdings Inc's I. Quarter Investments $ 48 Millions SRGA's Balance sheet
Surgalign Holdings Inc's I. Quarter Income $ 4 Millions Quarterly SRGA's Income Statement
SRGA's Income by Division See SRGA's Income by Division


SRGA Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Investments in Millions 49 31 28 103 298
Y / Y Investment Growth 56.35 % 10.72 % -72.46 % -65.46 % -
Net Income in Millions -55 -127 -34 -212 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -111.22 % -403.01 % -119.11 % -205.5 % -1.05 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SRGA's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SRGA's Competitors
Subscribers only: Roi for Surgalign Holdings Inc's Suppliers
Subscribers only: Return On Investment for SRGA's Customers

Other Ratios
SRGA's Roa SRGA's Inventory Turnover Ratio SRGA's Growth Rates SRGA's Dividend Statistics
SRGA's Profitability Ratios SRGA's Asset Turnover Ratio SRGA's Dividend Growth
SRGA's Roe SRGA's Valuation Ratios SRGA's Financial Strength Ratios SRGA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI


Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.